Category results for: Medicines for All
Medicines for All Initiative funded for third AIDS therapy
The Medicines for All Initiative has received approximately $5 million from the Bill & Melinda Gates Foundation to develop a more cost-effective way to manufacture Dolutegravir, a new HIV/AIDS therapy. The Initiative’s lead investigator is B. Frank Gupton, Ph.D., professor and chair in the Virginia Commonwealth University Department of Chemical & Life Science Engineering. “[Dolutegravir] […]
